Preimplantation Genetic Diagnosis (PGD)

Preimplantation Genetic Diagnosis (PGD) is a reproductive technology used to screen embryos for genetic abnormalities before they are implanted in the uterus during in vitro fertilization (IVF). PGD enables couples at risk of passing on genetic disorders to conceive embryos that are free from the specific genetic condition they carry. It also raises complex ethical considerations related to embryo selection, non-medical applications, access to care, and reproductive autonomy.

Applications of Preimplantation Genetic Diagnosis (PGD) includes

  • Prevention of genetic disorders
  • Family balancing
  • Reduced risk of genetic disorders
  • Increased pregnancy success rates

 

    Related Conference of Preimplantation Genetic Diagnosis (PGD)

    November 21-22, 2024

    11th World Congress on Epigenetics and Chromosome

    Dubai, UAE
    December 09-10, 2024

    17th World Congress on Stem Cell Research

    Dubai, UAE
    March 17-18, 2025

    8th Global Conference on Cell and Gene Therapy

    Paris, France
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany

    Preimplantation Genetic Diagnosis (PGD) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in